Australian media has recognised the significance of the recent launch of the GE HealthCare total body PET/CT instrument via two new research centres:
- ACRF Centre for Advanced Imaging-Guided Therapeutics
- ACRF Centre for Cellular Imaging of Precision Immunotherapy
Watch the 7NEWS Australia story: Melbourne’s world-first scanner hunting cancer cells in real time
Watch the SBS Australia story: New cancer scanning technology offering better diagnosis and personalised treatment
Watch the 7NEWS story: World-first total body cancer scanner unveiled in Melbourne
The stories highlight the outcomes of the scanner and centres for Australian patients, who set to benefit from the precision medicine, which is about moving away from “one-size fits all” therapeutic approaches.
Peter Mac’s Acting Chief Executive Karen Fox said the new centres “will accelerate the development of advanced imaging techniques and enhance our ability to predict how patients will respond to immunotherapy – ensuring more people can benefit from precision medicine.”
The Australian Cancer Research Foundation, National Imaging Facility, University of Melbourne and GE HealthCare were thanked on Tuesday for their support. The new Centre is headed by Professor Michael Hofman, Director of the Prostate Theranostics and Imaging Centre of Excellence (ProsTIC) at Peter Mac and Peter Mac’s Director of Medical Oncology, Professor Linda Mileshkin.